NaviFUS Corporation notes researchers at Linkou Chang Gung Memorial Hospital are investigating the use of Neuronavigation-guided FUS to repeatedly and temporarily open the blood-brain barrier and enhance bevacizumab’s efficacy in patients with recurrent glioblastoma.